Regulus sets IPO range

Regulus Therapeutics Inc. (San Diego, Calif.) amended its IPO and now plans to sell 4.5 million shares at $10-$12 per share. An $11 price would raise $50 million and value the company at $239 million. Last month, Regulus filed to raise up to $57.5 million. Lazard; Cowen; BMO Capital Markets; Needham; and Wedbush are underwriters. ...